Tag: TEMPO-2
Varied tenecteplase data may provide clarity on the drug’s exact role...
This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China,...
